Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Comparison of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor Rating Assessment Scale.

Ondo W, Hashem V, LeWitt PA, Pahwa R, Shih L, Tarsy D, Zesiewicz T, Elble R.

Mov Disord Clin Pract. 2017 Nov 23;5(1):60-65. doi: 10.1002/mdc3.12560. eCollection 2018 Jan-Feb.

2.

Tai Chi for Reducing Dual-task Gait Variability, a Potential Mediator of Fall Risk in Parkinson's Disease: A Pilot Randomized Controlled Trial.

Vergara-Diaz G, Osypiuk K, Hausdorff JM, Bonato P, Gow BJ, Miranda JG, Sudarsky LR, Tarsy D, Fox MD, Gardiner P, Thomas CA, Macklin EA, Wayne PM.

Glob Adv Health Med. 2018 May 17;7:2164956118775385. doi: 10.1177/2164956118775385. eCollection 2018.

3.

Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.

Graebner AK, Tarsy D, Shih LC, Vanderhorst V, Kulkarni O, Kaplan S, Simon DK.

Neurodegener Dis. 2017;17(1):38-43. Epub 2016 Sep 10.

PMID:
27614874
4.

Addition of a virtual reality component to treadmill training to reduce fall risk in older adults, including individuals with Parkinson's disease.

Tarsy D.

Mov Disord. 2016 Nov;31(11):1632. doi: 10.1002/mds.26843. Epub 2016 Oct 19. No abstract available.

PMID:
27759893
5.

Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.

Narayanaswami P, Geisbush T, Tarulli A, Raynor E, Gautam S, Tarsy D, Gronseth G.

Parkinsonism Relat Disord. 2016 Sep;30:73-7. doi: 10.1016/j.parkreldis.2016.07.001. Epub 2016 Jul 5.

PMID:
27406786
6.

Invasive Candida Infections in the ICU: Diagnosis and Therapy.

Hankovszky P, Társy D, Öveges N, Molnár Z.

J Crit Care Med (Targu Mures). 2015 Nov 10;1(4):129-139. doi: 10.1515/jccm-2015-0025. eCollection 2015 Oct. Review.

7.

Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor.

Parihar R, Alterman R, Papavassiliou E, Tarsy D, Shih LC.

Tremor Other Hyperkinet Mov (N Y). 2015 Jul 6;5:321. doi: 10.7916/D81V5D35. eCollection 2015.

8.

Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placement.

Smith KM, O'Connor M, Papavassiliou E, Tarsy D, Shih LC.

Parkinsonism Relat Disord. 2014 Apr;20(4):400-4. doi: 10.1016/j.parkreldis.2014.01.008. Epub 2014 Jan 20.

PMID:
24495709
9.

Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: UNITED STATES.

Tarsy D.

Neurol Clin Pract. 2013 Dec;3(6):482-483. doi: 10.1212/01.CPJ.0000437020.14670.67. No abstract available.

10.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC; National Parkinson Foundation Quality Improvement Initiative Investigators.

Parkinsonism Relat Disord. 2014 Mar;20(3):274-9. doi: 10.1016/j.parkreldis.2013.10.004. Epub 2013 Oct 16.

PMID:
24182524
11.

The current state and needs of north american movement disorders fellowship programs.

Shih LC, Tarsy D, Okun MS.

Parkinsons Dis. 2013;2013:701426. doi: 10.1155/2013/701426. Epub 2013 Jul 25.

12.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Sengupta S, Tarsy D, Joyce R, Jeyapalan S.

Mov Disord. 2013 Nov;28(13):1905-6. doi: 10.1002/mds.25574. Epub 2013 Jul 9. No abstract available.

PMID:
23839936
13.

Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections.

Kulkarni OC, Cox CA, Hedges TR 3rd, Tarsy D.

Parkinsonism Relat Disord. 2013 Aug;19(8):770-1. doi: 10.1016/j.parkreldis.2013.04.014. Epub 2013 May 13. No abstract available.

PMID:
23680422
14.

The "floating door sign" in Parkinson's disease.

Kulkarni O, Lafaver K, Tarsy D.

Parkinsonism Relat Disord. 2013 Sep;19(9):825-6. doi: 10.1016/j.parkreldis.2013.04.013. Epub 2013 May 7.

PMID:
23660546
15.

Initial treatment of Parkinson's disease: an update.

Kaplan S, Tarsy D.

Curr Treat Options Neurol. 2013 Aug;15(4):377-84. doi: 10.1007/s11940-013-0236-7.

PMID:
23645294
16.

Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it?

Shih LC, LaFaver K, Lim C, Papavassiliou E, Tarsy D.

Parkinsonism Relat Disord. 2013 Jul;19(7):676-9. doi: 10.1016/j.parkreldis.2013.03.006. Epub 2013 Apr 11.

PMID:
23582712
17.

Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved?

Kulkarni O, Lafaver K, Papavassiliou E, Tarsy D, Shih LC.

Mov Disord. 2013 Apr;28(4):554-5. doi: 10.1002/mds.25299. Epub 2013 Feb 6. No abstract available.

PMID:
23389961
18.

Psychogenic facial movement disorders: clinical features and associated conditions.

Fasano A, Valadas A, Bhatia KP, Prashanth LK, Lang AE, Munhoz RP, Morgante F, Tarsy D, Duker AP, Girlanda P, Bentivoglio AR, Espay AJ.

Mov Disord. 2012 Oct;27(12):1544-51. doi: 10.1002/mds.25190. Epub 2012 Oct 2.

19.

Reliability of a new scale for essential tremor.

Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T.

Mov Disord. 2012 Oct;27(12):1567-9. doi: 10.1002/mds.25162. Epub 2012 Oct 2.

20.

Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease.

Tarsy D.

JAMA. 2012 Jun 6;307(21):2305-14. doi: 10.1001/jama.2012.4829.

PMID:
22706836
21.

Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders.

Shih LC, Piel J, Warren A, Kraics L, Silver A, Vanderhorst V, Simon DK, Tarsy D.

Parkinsonism Relat Disord. 2012 Jun;18(5):548-52. doi: 10.1016/j.parkreldis.2012.02.009. Epub 2012 Mar 19.

PMID:
22436653
22.

Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease.

Shih LC, Tarsy D.

Neuromodulation. 2011 May-Jun;14(3):208-13; discussion 213. doi: 10.1111/j.1525-1403.2011.00350.x. Epub 2011 Apr 1.

PMID:
21992241
23.

Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure.

Shih LC, Vanderhorst V, Papavassiliou E, Tarsy D.

Neuromodulation. 2011 Nov-Dec;14(6):512-4; discussion 514. doi: 10.1111/j.1525-1403.2011.00379.x. Epub 2011 Aug 19.

PMID:
21854491
24.

Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.

Tarsy D, Lungu C, Baldessarini RJ.

Handb Clin Neurol. 2011;100:601-16. doi: 10.1016/B978-0-444-52014-2.00043-4. Review.

PMID:
21496610
25.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488298
26.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488297
27.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469-70. No abstract available.

PMID:
21488296
28.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469. No abstract available.

PMID:
21488277
29.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488252
30.

The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzińska M, Pfeiffer RF, Le C, LeDoux MS.

Mov Disord. 2011 Feb 15;26(3):549-52. doi: 10.1002/mds.23551. Epub 2011 Mar 2. Erratum in: Mov Disord. 2012 Mar;27(3):465.

31.

Home monitoring of patients with Parkinson's disease via wearable technology and a web-based application.

Patel S, Chen BR, Buckley T, Rednic R, McClure D, Tarsy D, Shih L, Dy J, Welsh M, Bonato P.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:4411-4. doi: 10.1109/IEMBS.2010.5627124.

PMID:
21096462
32.

A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors.

Chen BR, Patel S, Buckley T, Rednic R, McClure DJ, Shih L, Tarsy D, Welsh M, Bonato P.

IEEE Trans Biomed Eng. 2011 Mar;58(3):831-6. doi: 10.1109/TBME.2010.2090044. Epub 2010 Oct 28.

PMID:
21041152
33.

Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment.

Lungu C, Tarulli AW, Tarsy D, Mongiovi P, Vanderhorst VG, Rutkove SB.

Clin Neurophysiol. 2011 May;122(5):1027-31. doi: 10.1016/j.clinph.2010.09.013. Epub 2010 Oct 12.

34.

Laserlight cues for gait freezing in Parkinson's disease: an open-label study.

Donovan S, Lim C, Diaz N, Browner N, Rose P, Sudarsky LR, Tarsy D, Fahn S, Simon DK.

Parkinsonism Relat Disord. 2011 May;17(4):240-5. doi: 10.1016/j.parkreldis.2010.08.010. Epub 2010 Sep 3.

PMID:
20817535
35.

Case records of the Massachusetts General Hospital. Case 17-2010 - a 29-year-old woman with flexion of the left hand and foot and difficulty speaking.

Tarsy D, Sweadner KJ, Song PC.

N Engl J Med. 2010 Jun 10;362(23):2213-9. doi: 10.1056/NEJMcpc1002112. No abstract available.

PMID:
20558373
36.

Novel THAP1 sequence variants in primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS.

Neurology. 2010 Jan 19;74(3):229-38. doi: 10.1212/WNL.0b013e3181ca00ca.

37.

Does subthalamotomy have a place in the treatment of Parkinson's disease?

Tarsy D.

J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):939-40. doi: 10.1136/jnnp.2008.163949. No abstract available.

PMID:
19684228
38.

Deep brain stimulation effects on gait variability in Parkinson's disease.

Hausdorff JM, Gruendlinger L, Scollins L, O'Herron S, Tarsy D.

Mov Disord. 2009 Aug 15;24(11):1688-92. doi: 10.1002/mds.22554.

PMID:
19554569
39.

Tardive dyskinesia due to aripiprazole: report of 2 cases.

Lungu C, Aia PG, Shih LC, Esper CD, Factor SA, Tarsy D.

J Clin Psychopharmacol. 2009 Apr;29(2):185-6. doi: 10.1097/JCP.0b013e31819a4bd5. No abstract available.

PMID:
19512985
40.

Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.

Addy C, Assaid C, Hreniuk D, Stroh M, Xu Y, Herring WJ, Ellenbogen A, Jinnah HA, Kirby L, Leibowitz MT, Stewart RM, Tarsy D, Tetrud J, Stoch SA, Gottesdiener K, Wagner J.

J Clin Pharmacol. 2009 Jul;49(7):856-64. doi: 10.1177/0091270009336735. Epub 2009 Jun 2.

PMID:
19491335
41.

Early brain abscess: A rare complication of deep brain stimulation.

Vanderhorst VG, Papavassiliou E, Tarsy D, Shih L.

Mov Disord. 2009 Jul 15;24(9):1395-7. doi: 10.1002/mds.22569. No abstract available.

PMID:
19412938
42.

High-throughput mutational analysis of TOR1A in primary dystonia.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, Zhao Y, LeDoux MS.

BMC Med Genet. 2009 Mar 11;10:24. doi: 10.1186/1471-2350-10-24.

43.

Beating a dead horse: dopamine and Parkinson disease.

Tarsy D, Simon DK.

Neurology. 2008 Nov 11;71(20):1651; author reply 1651-2. doi: 10.1212/01.wnl.0000339368.54460.68. No abstract available.

PMID:
19001260
44.

Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.

Connor GS, Edwards K, Tarsy D.

Clin Neuropharmacol. 2008 Mar-Apr;31(2):97-103. doi: 10.1097/WNF.0b013e3180d09969.

PMID:
18382182
45.

Diabetic gastroparesis.

Tarsy D.

N Engl J Med. 2007 Jul 26;357(4):419; author reply 419-20. No abstract available.

PMID:
17663032
46.

Deep brain stimulation for the treatment of atypical parkinsonism.

Shih LC, Tarsy D.

Mov Disord. 2007 Nov 15;22(15):2149-55. Review.

PMID:
17659638
47.

Deep-brain stimulation for dystonia: new twists in assessment.

Tarsy D.

Lancet Neurol. 2007 Mar;6(3):201-2. No abstract available.

PMID:
17303521
48.

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.

Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ.

Neurology. 2006 Dec 26;67(12):2233-5.

PMID:
17190952
49.

Dystonia.

Tarsy D, Simon DK.

N Engl J Med. 2006 Aug 24;355(8):818-29. Review. No abstract available.

PMID:
16928997
50.

Treatment of dystonia.

Bhidayasiri R, Tarsy D.

Expert Rev Neurother. 2006 Jun;6(6):863-86. Review.

PMID:
16784410

Supplemental Content

Support Center